NICE England Update on SCENESSE
Filed with ASX · · 2 pages · English
Clinuvel Pharmaceuticals Limited on 6ix
Story so far
Earlier from Clinuvel Pharmaceuticals
- CLINUVEL reaches agreement on German SCENESSE pricing
- CLINUVEL agrees with FDA on New Drug Application timelines
- SCENESSE - NICE England Update
- FDA Schedules Pre-NDA Meeting for SCENESSE
- Clinuvel completes combination therapy pre-clinical study
Later from Clinuvel Pharmaceuticals
- Amended Appendix 4C - quarterly
- Preliminary Final Report
- CLINUVEL provides update on SCENESSE FDA filing
- Preliminary assessment received from NICE
- CLINUVEL hosts European EPP Expert Meeting
Follow Clinuvel Pharmaceuticals into a list and get an email when it puts out news.
Follow Clinuvel Pharmaceuticals